Inventor · disambiguated record
Zhiren Xia
Also filed as: XIA ZHIREN
8 granted patents·4 pending applications·46 citations·filing 2002–2013
83Inventor score
Top patents by PatentIndex Score
12 records- 0188US7528134B2Acetamides and benzamides that are useful in treating sexual dysfunctionABBOTT LAB·Filed 2003·Granted May 5, 2009·26 cites·9 claims
- 0281US8648074B2Substituted octahydropyrrolo[1,2-a]pyrazine sulfonamides as calcium channel blockersABBVIE INC·Filed 2012·Granted Feb 11, 2014·6 cites·25 claims
- 0381US7956185B2Cyclobut-3-ene-1,2,-dione inhibitors of polo-like kinasesABBOTT LAB·Filed 2007·Granted Jun 7, 2011·5 cites·5 claims
- 0479US8101614B2Substituted pyrrolo [1,2-a] pyrazines as calcium channel blockersZHANG QINGWEI·Filed 2010·Granted Jan 24, 2012·5 cites·15 claims
- 0577US7468371B2Tricyclic pyrazole kinase inhibitorsABBOTT LAB·Filed 2005·Granted Dec 23, 2008·4 cites·20 claims
- 0659US8741899B2(4-chloro-2-fluoro-N-(2-fluorophenyl)-5-[(8aR)-hexahydropyrrolo-[1,2-a]pyrazin-2(1H)-ylcarbonyl]-benzenesulfonamide, and pharmaceutically acceptable salts thereofABBVIE INC·Filed 2013·Granted Jun 3, 2014·0 cites·2 claims
- 0753US8404719B2Substituted piperidinylcarbonylbenzenesulfonamides as calcium channel blockersZHANG QINGWEI·Filed 2011·Granted Mar 26, 2013·0 cites·5 claims
- 0843US8669255B2Substituted octahydropyrrolo[1,2-a]pyrazines as calcium channel blockersABBVIE INC·Filed 2012·Granted Mar 11, 2014·0 cites·32 claims
- 0941US2013178477A1Methods of treating diabetic neuropathy using benzenesulfonamidesABBVIE INC·Filed 2013·Application pending·0 cites
- 1040US2004029887A1Acetamides and benzamides that are useful in treating sexual dysfunctionFiled 2003·Application pending·0 cites
- 1140US2006009461A1Acetamides and benzamides that are useful in treating sexual dysfunctionBHATIA PRAMILA A·Filed 2005·Application pending·0 cites
- 1240US2004121994A1Novel amides that activate soluble guanylate cyclaseFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Zhiren Xia files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →